Allen Moseley

Allen Moseley is a seasoned investor and Managing General Partner at Noro-Moseley Partners (NMP), a venture capital firm that invests in early-stage healthcare and technology companies. With over twenty years of experience in the healthcare industry, Moseley has an outstanding track record of investing in various sectors, including healthcare information technology and healthcare services.

Before joining NMP in 1998, Moseley served as an investment banker with Bowles Hollowell Conner & Company and The Robinson-Humphrey Company, where he advised clients on various transactions, including IPOs, mergers, and acquisitions. He is a graduate of the Harvard Business School, where he earned his MBA, and the University of North Carolina, where he was a member of Phi Beta Kappa.

At NMP, Allen Moseley leads the healthcare practice and oversees the firm's investments in healthcare services, payer and provider-facing technologies, and tech-enabled service platforms. He represents NMP on the boards of Elligo Health Research, Icario, Medix Infusion, Pure Life Renal, and Upward Health.

Apart from his work at NMP, Moseley has also served on the boards of several other companies, including Apex Analytix, Bloodhound Technologies, Hospicelink, Navitas Credit Corp., RemitDATA, Renal CarePartners, U.S. Radiosurgery, Valor Healthcare, and Wellcentive.

His expertise in healthcare investing and background in investment banking has made him a sought-after speaker and mentor, and he serves on the Advisory Board of the Institute for the Arts and Humanities at the University of North Carolina at Chapel Hill.